Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/25660
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.contributor.author | Kamalı, Sevil | - |
dc.date.accessioned | 2022-04-08T06:51:07Z | - |
dc.date.available | 2022-04-08T06:51:07Z | - |
dc.date.issued | 2012-07 | - |
dc.identifier.citation | Dalkılıç, E. vd. (2012). "Rituximab as a new therapeutic option in granulomatosis with polyangiitis: A report of two cases". Modern Rheumatology, 22(3), 463-466. | en_US |
dc.identifier.issn | 1439-7595 | - |
dc.identifier.issn | 1439-7609 | - |
dc.identifier.uri | https://doi.org/10.1007/s10165-011-0507-7 | - |
dc.identifier.uri | https://www.tandfonline.com/doi/abs/10.3109/s10165-011-0507-7 | - |
dc.identifier.uri | http://hdl.handle.net/11452/25660 | - |
dc.description.abstract | Findings of several reports suggest that rituximab, a chimeric monoclonal anti-CD20 antibody causing B-lymphocyte depletion, might represent a treatment option for people with granulomatosis with polyangiitis (GPA) (former Wegener's granulomatosis). This study presents the results of rituximab treatment in two patients with treatment-refractory GPA. First patient received rituximab for a granulomatous posterior orbital mass lesion, and eye symptoms were resolved after three courses of treatment. The second patient had eye and paranasal sinus involvement and benefited from two courses of rituximab treatment, with significant clinical improvement. Rituximab may represent an effective novel treatment for remission induction in GPA. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Rheumatology | en_US |
dc.subject | Rituximab | en_US |
dc.subject | Granulomatosis with polyangiitis | en_US |
dc.subject | Ocular involvement | en_US |
dc.subject | Wegeners-granulomatosis | en_US |
dc.subject | Vasculitis | en_US |
dc.subject | Cyclophosphamide | en_US |
dc.subject | Methotrexate | en_US |
dc.subject | Efficacy | en_US |
dc.subject | Trial | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antibodies, antineutrophil cytoplasmic | en_US |
dc.subject.mesh | Antibodies, monoclonal, murine-derived | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunologic factors | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.mesh | Wegener granulomatosis | en_US |
dc.title | Rituximab as a new therapeutic option in granulomatosis with polyangiitis: A report of two cases | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000305275300019 | tr_TR |
dc.identifier.scopus | 2-s2.0-84865388618 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/İç Hastalıkları Anabilim Dalı/Romatoloji Bölümü. | tr_TR |
dc.identifier.startpage | 463 | tr_TR |
dc.identifier.endpage | 466 | tr_TR |
dc.identifier.volume | 22 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Modern Rheumatology | en_US |
dc.contributor.buuauthor | Dalkılıç, Ediz | - |
dc.contributor.buuauthor | Alkış, Nihan | - |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 21847703 | tr_TR |
dc.subject.wos | Rheumatology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 6506739457 | tr_TR |
dc.contributor.scopusid | 26533912000 | tr_TR |
dc.subject.scopus | Wegener Granulomatosis; ANCA Associated Vasculitis; Antineutrophil Cytoplasmic Antibodies | en_US |
dc.subject.emtree | Azathioprine | en_US |
dc.subject.emtree | Cyclophosphamide | en_US |
dc.subject.emtree | Methotrexate | en_US |
dc.subject.emtree | Methylprednisolone | en_US |
dc.subject.emtree | Neutrophil cytoplasmic antibody | en_US |
dc.subject.emtree | Prednisolone | en_US |
dc.subject.emtree | Rituximab | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Computer assisted tomography | en_US |
dc.subject.emtree | Episcleritis | en_US |
dc.subject.emtree | Eye redness | en_US |
dc.subject.emtree | Feet gangrenous lesion | en_US |
dc.subject.emtree | Fever | en_US |
dc.subject.emtree | Foot amputation | en_US |
dc.subject.emtree | Foot disease | en_US |
dc.subject.emtree | Headache | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Malaise | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Nose crusting | en_US |
dc.subject.emtree | Nose disease | en_US |
dc.subject.emtree | Nuclear magnetic resonance imaging | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Sinusitis | en_US |
dc.subject.emtree | Wegener granulomatosis | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.